2022
DOI: 10.37279/2224-6444-2021-11-2-11-18
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Cardiotoxic Side Effects in the Administration of Organotin Compounds at the Preclinical Stage of the Study

Abstract: The most important task of preclinical research of promising candidates for antitumor drugs is to assess the safety of their use. The study of the cardiotoxicity of organotin compounds (OOS) dimethyltin bis (3,5-di-tert-butyl-4-hydroxy- phenylthiolate) (Me3) and (3,5-di-tert-butyl-4-hydroxyphenylthiolate) triphenyltin (Me5) was carried out with a single intragastric administration at the maximum tolerated dose (MTD) in an experiment on 30 Wistar rats (female) weighing 190-210gr. According to the results of pat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 0 publications
0
0
0
Order By: Relevance